Vulnerability for ventricular arrhythmias in patients with chronic coronary total occlusion.
Amira AssafRoberto DilettiMark G HoogendijkMarisa van der GraafFelix ZijlstraTamas Szili-TorokSing-Chien YapPublished in: Expert review of cardiovascular therapy (2020)
Studies in recipients of an implantable cardioverter-defibrillator (ICD) have shown that a CTO is an independent predictor of appropriate ICD therapy. The myocardial territory supplied by a CTO is a pro-arrhythmogenic milieu characterized by scar tissue, large scar border zone, hibernating myocardium, residual ischemia despite collaterals, areas of slow conduction, and heterogeneity in repolarization. Restoring coronary flow by revascularization might be associated with electrical homogenization as reflected by a decrease in QT(c) dispersion, decrease in T wave peak-to-end interval, reduction of late potentials, and decrease in scar border zone area. Future research should explore whether CTO revascularization results in a lower burden of ventricular arrhythmias. Furthermore, risk stratification of CTO patients without severe LV dysfunction is interesting to identify potential ICD candidates. Potential tools for risk stratification are the use of electrocardiographic parameters, body surface mapping, electrophysiological study, and close rhythm monitoring using an insertable cardiac monitor.
Keyphrases
- left ventricular
- coronary artery disease
- coronary artery
- heart failure
- aortic stenosis
- end stage renal disease
- percutaneous coronary intervention
- coronary artery bypass grafting
- newly diagnosed
- wound healing
- climate change
- high resolution
- prognostic factors
- mitral valve
- drug induced
- stem cells
- early onset
- kidney transplantation
- cell therapy
- mass spectrometry
- blood pressure
- current status